跳至主要内容
临床试验/NCT04323787
NCT04323787已完成不适用

Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry and Validation of C2D2 (Critical Care Data Dictionary)

Mayo Clinic4 个研究点 分布在 1 个国家目标入组 100,000 人开始时间: 2020年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
100,000
试验地点
4
主要终点
ICU and hospital mortality of COVID-19 patients

研究概览

简要总结

Researchers are creating a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.

详细描述

Investigators aim is to create a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.

Such a set of standards would increase the quality of single and multi-center studies, national registries as well as aggregation syntheses such as meta-analyses. It will also be of utmost importance in tiring times of public health emergencies and will help understand practice variability and outcomes during COVID-19 pandemic.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • COVID-19 PCR positive (within 7 days)
  • COVID-19 PCR pending
  • COVID-19 high clinical suspicion

排除标准

  • Patient without Prior Research Authorization (applicable to Mayo Clinic sites)
  • Non COVID-19 related admissions
  • Repeated Admission to ICUs/Hospital

结局指标

主要结局

ICU and hospital mortality of COVID-19 patients

时间窗: 7 days

Primary outcome will be to measure ICU and hospital mortality up to 7 days of COVID-19 patients

次要结局

  • 30 days mortality(30 days)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Juan Pablo Domecq Garces

Principal Investigator

Mayo Clinic

研究点 (4)

Loading locations...

相似试验